RT Journal T1 ANTIOXIDANT PROPERTIES AND ANTI-DIABETIC EFFICACY OF A POLYHERBAL FORMULATION ADVOCATED IN THE SOUTHWEST OF ALGERIA FOR THE MANAGEMENT OF DIABETES: IN VITRO, IN VIVO, AND MOLECULAR DOCKING INVESTIGATIONS A1 Abdelkrim Mlouki A1 Wafâa Tehami A1 Lahcene Kardja A1 Malika Bahiani A1 Abdelhafid NANI JF Journal of Animal and Plant Sciences JO JAPS SN 1018-7081 VO 36 IS 6 YR 2026 FD 2026 DO DOI https://doi.org/10.36899/JAPS.2026.6.0139 AB
Diabetes mellitus is a leading cause of worldwide mortality, and current diabetes medications have serious adverse effects. Therefore, herbal medicine is gaining popularity as a complementary treatment for diabetes. This study investigated the polyphenolic content and antioxidant activity of a polyherbal formulation (PHF), which is used in traditional medicine in the Adrar region (Southwestern Algeria) for the management of diabetes mellitus. We also investigated the anti-diabetic activity of infusions from PHF (i.e., PHFI, 0.5%, and 1%) and PHF-based diets (i.e., PHFD, 25% and 50%) in streptozotocin-induced diabetic rats. Thirty male Wistar rats were used in this study and randomly divided into six groups (n=5 per group) using a completely randomized design (CRD). Diabetes was induced by a single (i.p) injection of streptozotocin (60 mg/kg), followed by oral administration of either PHF infusions or diets for 28 days. A molecular docking analysis using AutoDock Vina was conducted to predict the binding affinity of p-Coumaric acid (p-CA), the most dominant phenolic compound found in the main PHF ingredients towards four diabetes-related target proteins (AMPK, LKB1, ChREBP, and TBC1D1). Phytochemical assessment revealed the abundance of tannins, flavonoids, and polyphenols (0.87 mg CE/100 g DW, 0.82 mg CE/g DW, and 1.43 mg GAE/g DW, respectively) in the crude extract of the PHF. In vitro DPPH, FRAP, and ABTS assays revealed that the crude extract of PHF possesses significant antioxidant activity against all tested radicals, with an IC50 of 0.025 mg/mL for DPPH. Most experimental groups (i.e., PHFD, 25%; PHFD, 50%; and PHFI, 1%) demonstrated a significant (P < 0.05) improvement in glycemia, corticosterone levels, hepatic biomarkers, and lipid profile (HDL, LDL, TG, and TC). In silico results indicate that p-CA demonstrates superior binding affinities and interactions with the target proteins compared to metformin, with binding affinities of −6.6, −5.6, −6.5, and −5.5 kcal/mol for AMPK, LKB1, ChREBP, and TBC1D1, respectively. The considerable anti-hyperlipidemic, antioxidant, and anti-diabetic activities of the studied FPH validate its application in complementary and alternative medicine for diabetes management.
K1 Diabetes mellitus, Wistar rat, polyherbal formulation (PHF), antioxidant, molecular docking PB Pakistan Agricultural Scientists Forum LK https://thejaps.org.pk/AbstractView.aspx?mid=2025-JAPS-1386